Showing results (21-30 of 65) with videos related to
Sort By:
Pageof 7
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
The EQ-5D-5L Value Set for England: Response to the "Quality Assurance"Ben van Hout, Brendan Mulhern, Yan Feng, et al.BMJ Open Diabetes Research & Care|March 20, 2021
Time trends in the incidence of clinically diagnosed type 2 diabetes and pre-diabetes in the UK 2009-2018: a retrospective cohort studyKingshuk Pal, Laura Horsfall, Manuj Sharma, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 1, 2017
How Should Discrete Choice Experiments with Duration Choice Sets Be Presented for the Valuation of Health States?Brendan Mulhern, Richard Norman, Koonal Shah, et al.Pharmacoeconomics|October 5, 2025
The Influence of Perspective on the Valuation of the EQ-5D-Y-3L: A Comparison Using the OPUF Tool and a Discrete Choice ExperimentJake Hitch, Gayathri Kumar, Paul Schneider, et al.Public Health in Practice (Oxford, England)|September 14, 2022
Professional workforce training needs for Health Impact Assessment in spatial planning: A cross sectional surveyManuj Sharma, Andrew Netherton, Katrina McLarty, et al.Journal of Health Economics and Outcomes Research|April 17, 2023
Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and ValuationDerralynn Hughes, Andrew Lenny, Koonal Shah, et al.Journal of Health Services Research & Policy|July 7, 2012
Is the aim of the English health care system to maximize QALYs?Koonal Shah, Cecile Praet, Nancy Devlin, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2016
Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?Brendan Mulhern, Koonal Shah, Mathieu F Bas Janssen, et al.International Journal of Technology Assessment in Health Care|July 15, 2015
PAYER PERSPECTIVES ON FUTURE ACCEPTABILITY OF COMPARATIVE EFFECTIVENESS AND RELATIVE EFFECTIVENESS RESEARCHRachael Moloney, Penny Mohr, Emma Hawe, et al.Pharmacoeconomics|April 17, 2016
EuroQol Protocols for Time Trade-Off Valuation of Health OutcomesMark Oppe, Kim Rand-Hendriksen, Koonal Shah, et al.Pageof 7